Abstract:Introduction The study aims to explore the utility of BDNF Val66Met polymorphism as a potential biomarker in Indian bipolar disorder patients and its correlation with clinical characteristics. Objectives Genotyping Val66Met in BDNF gene Exploring its association with bipolar disorder (BD). Methods 150 consenting BD patients and matched controls were recruited using a case-control study design. BD severity was assessed using Young's mania rating scale and the Clinical Global Impression - Severity (CGI-S) scale. BDNF Val66Met polymorphism was identified through real-time PCR after DNA extraction. Data was tested for normal distribution. Genotype frequencies between two groups were compared and the Hardy-Weinberg equilibrium assumptions were tested using Chi-Square tests. Clinical-genotypic associations were explored using the Kruskal-Wallis test and confirmed using hierarchical regression. Results Our sample had more males (60%) than females (40%) with mean age of 35.05 years. Most patients had established bipolar disorder and were severely ill (CGI: 38.75, YMRS). Val66Met SNP genotype frequency differed significantly between cases and controls. Val66Val genotype and Val allele were higher in cases. Results consistent with Hardy-Weinberg equilibrium. Table 1. Genotype frequencies of BDNF (rs6265) in cases and controls GENOTYPE CC CT TT CASES 94(62.6%) 47(31.3%) 9(6%) CONTROL 71(47.3%) 69(46%) 10(6.6%) CHI-SQUARE- 7.431 DF(Degree of freedom) - 2 p-value- 0.024 Table 2. Dominant genotype frequencies in cases and controls DOMINANT GENOTYPE CC CT+TT CASES 94(62.6%) 56(37.3%) CONTROLS 71(47.3%) 79(52.6) CHI-SQUARE-7.125 DF(Degree of freedom)-1 p-value-0.007 Table 3. Allelic frequencies of BDNF (rs6265) in BD cases and healthy controls ALLELIC VARIATION C T CASES 235(78.3%) 65(21.6%) CONTROLS 211(70.3%) 89(29.6%) CHI-SQUARE-5.032 DF(Degree of freedom)-1 p-value- 0.024 Conclusions Our study found that Val66Val genotype and Val allele were higher in cases and could be a potential biomarker for bipolar disorder (BD), which is consistent with previous research conducted on the European population. However, further investigations are required to gain a more comprehensive understanding of its impact on BD, including its association with serum BDNF levels, treatment outcomes, and a more diverse study population. Disclosure of Interest None Declared

Association Between Brain-Derived Neurotrophic Factor Genetic Polymorphism Val66Met and Susceptibility to Bipolar Disorder: a Meta-Analysis

Association Of Brain-Derived Neurotrophic Factor Genetic Val66met Polymorphism With Severity Of Depression, Efficacy Of Fluoxetine And Its Side Effects In Chinese Major Depressive Patients

Association of BDNF gene polymorphism with bipolar disorders in Han Chinese population.

Association Between Brain-Derived Neurotrophic Factor Val66Met Polymorphism and Methamphetamine Use Disorder: A Meta-Analysis

Positive Association Between the Brain-Derived Neurotrophic Factor (bdnf) Gene and Bipolar Disorder in the Han Chinese Population

Association of BDNF Val66Met polymorphism with both baseline HRQOL scores and improvement in HRQOL scores in Chinese major depressive patients treated with fluoxetine.

Association of the Brain-Derived Neurotrophic Factor Gene and Bipolar Disorder with Early Age of Onset in Mainland China

The brain-derived neurotrophic-factor (BDNF) val66met polymorphism is associated with geriatric depression: a meta-analysis.

Comparison of Val66met Polymorphism of BDNF gene in patients of bipolar disorder and healthy controls.

Brain-derived Neurotrophic Factor Gene C-270T and Val66Met Functional Polymorphisms and Risk of Schizophrenia: A Moderate-Scale Population-Based Study and Meta-Analysis

Evaluation of the Relationship Between BDNF Val66Met Gene Polymorphism and Attention Deficit Hyperactivity Disorder: A Meta-Analysis

Brain-Derived Neurotrophic Factor Gene C-270t and Va166met Functional Polymorphisms and Risk of Schizophrenia: A Moderate-Scale Population-Based Study and Meta-Analysis

The BDNF gene Val66Met polymorphism as a modifier of psychiatric disorder susceptibility: progress and controversy

An association study of brain-derived neurotrophic factor gene polymorphism in bipolar disorders

Association Between the BDNF G196A and C270T Polymorphisms and Parkinson's Disease: a Meta-Analysis

BDNF Val66Met Polymorphism and Plasma Levels in Chinese Han Population with Obsessive-Compulsive Disorder and Generalized Anxiety Disorder.

Association of the Brain-Derived Neurotrophic Factor (BDNF) Gene Polymorphisms with Early-Onset and Female Schizophrenia in the Chinese Population

The BDNF Val66Met polymorphism serves as a potential marker of body weight in patients with psychiatric disorders

Val66Met Polymorphism in BDNF Has No Sexual and APOE Ε4 Status-Based Dimorphic Effects on Susceptibility to Alzheimer's Disease: Evidence from an Updated Meta-Analysis of Case-Control Studies and High-Throughput Genotyping Cohorts.

O-65 - Effect of Brain-derived Neurotrophic Factor (bdnf) Val66met Polymorphism on Early Onset Schizophrenia in Chinese Han Population

The Val/Met Functional Polymorphism in Comt Confers Susceptibility to Bipolar Disorder: Evidence from an Association Study and A Meta-Analysis